Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Esaxerenone vs Olmesartan in Essential Hypertension
NCT02848170Phase 3Completed
- Sponsor
- Daiichi Sankyo Co., Ltd.
- Start
- Aug 2016
- Primary completion
- Apr 2017
- Countries
- 1
01
Overview
A Phase 3 trial of esaxerenone in essential hypertension, sponsored by Daiichi Sankyo Co., Ltd.. Started Aug 2016; status: completed.
02
Drugs
esaxerenone
03
Conditions
essential hypertension
Beyond the preview
Go deeper on NCT02848170.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02848170.